The Millennia-Long Development of Drugs Associated with the 80-Year-Old Artificial Intelligence Story: The Therapeutic Big Bang?

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2024 Jun 27

PMID 38930784

Authors

Aurore Crouzet

Nicolas Lopez

Benjamin Riss Yaw

Yves Lepelletier

Luc Demange

Affiliations

Soon will be listed here.

Abstract

The journey of drug discovery (DD) has evolved from ancient practices to modern technology-driven approaches, with Artificial Intelligence (AI) emerging as a pivotal force in streamlining and accelerating the process. Despite the vital importance of DD, it faces challenges such as high costs and lengthy timelines. This review examines the historical progression and current market of DD alongside the development and integration of AI technologies. We analyse the challenges encountered in applying AI to DD, focusing on drug design and protein-protein interactions. The discussion is enriched by presenting models that put forward the application of AI in DD. Three case studies are highlighted to demonstrate the successful application of AI in DD, including the discovery of a novel class of antibiotics and a small-molecule inhibitor that has progressed to phase II clinical trials. These cases underscore the potential of AI to identify new drug candidates and optimise the development process. The convergence of DD and AI embodies a transformative shift in the field, offering a path to overcome traditional obstacles. By leveraging AI, the future of DD promises enhanced efficiency and novel breakthroughs, heralding a new era of medical innovation even though there is still a long way to go.

Citing Articles

The Goldilocks Zone: Finding the right balance of user and institutional risk for suicide-related generative AI queries.

VAN Meter A, Wheaton M, Cosgrove V, Andreadis K, Robertson R PLOS Digit Health. 2025; 4(1):e0000711.

PMID: 39774367 PMC: 11709298. DOI: 10.1371/journal.pdig.0000711.

References

Buterez D, Janet J, Kiddle S, Lio P . MF-PCBA: Multifidelity High-Throughput Screening Benchmarks for Drug Discovery and Machine Learning. J Chem Inf Model. 2023; 63(9):2667-2678. PMC: 10170507. DOI: 10.1021/acs.jcim.2c01569. View

AbdAlhafiz A, Elleboudy N, Aboshanab K, Aboulwafa M, Hassouna N . Phenotypic and genotypic characterization of linezolid resistance and the effect of antibiotic combinations on methicillin-resistant Staphylococcus aureus clinical isolates. Ann Clin Microbiol Antimicrob. 2023; 22(1):23. PMC: 10069030. DOI: 10.1186/s12941-023-00574-2. View

Abbott A . Paracelsus. Nature. 1993; 366(6451):98. DOI: 10.1038/366098b0. View

Tran-Nguyen V, Junaid M, Simeon S, Ballester P . A practical guide to machine-learning scoring for structure-based virtual screening. Nat Protoc. 2023; 18(11):3460-3511. DOI: 10.1038/s41596-023-00885-w. View

. Ancient Egyptian medicine. Lancet. 1972; 2(7771):272-4. DOI: 10.1016/s0140-6736(72)91700-x. View

Tran T, Wibowo A, Tayara H, Chong K . Artificial Intelligence in Drug Toxicity Prediction: Recent Advances, Challenges, and Future Perspectives. J Chem Inf Model. 2023; 63(9):2628-2643. DOI: 10.1021/acs.jcim.3c00200. View

Pina A, Hussain A, Roque A . An historical overview of drug discovery. Methods Mol Biol. 2010; 572:3-12. DOI: 10.1007/978-1-60761-244-5_1. View

Gershell L, Atkins J . A brief history of novel drug discovery technologies. Nat Rev Drug Discov. 2003; 2(4):321-7. DOI: 10.1038/nrd1064. View

Abbasi M, Santos B, Pereira T, Sofia R, Monteiro N, Simoes C . Designing optimized drug candidates with Generative Adversarial Network. J Cheminform. 2022; 14(1):40. PMC: 9233801. DOI: 10.1186/s13321-022-00623-6. View

10.

Jia W, Li W, Li Z, Li P . An all-in-one targeted protein degradation platform guided by degradation condensates-bridging bi-specific nanobodies. Cell Res. 2024; 34(5):389-392. PMC: 11061270. DOI: 10.1038/s41422-024-00942-3. View

11.

Kim K, Macruz F, Wu D, Bridge C, McKinney S, Al Saud A . Point-of-care AI-assisted stepwise ultrasound pneumothorax diagnosis. Phys Med Biol. 2023; 68(20). DOI: 10.1088/1361-6560/acfb70. View

12.

DSouza S, Kv P, Balaji S . Training recurrent neural networks as generative neural networks for molecular structures: how does it impact drug discovery?. Expert Opin Drug Discov. 2022; 17(10):1071-1079. DOI: 10.1080/17460441.2023.2134340. View

13.

Jimenez-Luna J, Grisoni F, Weskamp N, Schneider G . Artificial intelligence in drug discovery: recent advances and future perspectives. Expert Opin Drug Discov. 2021; 16(9):949-959. DOI: 10.1080/17460441.2021.1909567. View

14.

Ivanenkov Y, Polykovskiy D, Bezrukov D, Zagribelnyy B, Aladinskiy V, Kamya P . Chemistry42: An AI-Driven Platform for Molecular Design and Optimization. J Chem Inf Model. 2023; 63(3):695-701. PMC: 9930109. DOI: 10.1021/acs.jcim.2c01191. View

15.

Ren F, Aliper A, Chen J, Zhao H, Rao S, Kuppe C . A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models. Nat Biotechnol. 2024; 43(1):63-75. PMC: 11738990. DOI: 10.1038/s41587-024-02143-0. View

16.

Hassanzadeh P, Atyabi F, Dinarvand R . The significance of artificial intelligence in drug delivery system design. Adv Drug Deliv Rev. 2019; 151-152:169-190. DOI: 10.1016/j.addr.2019.05.001. View

17.

Ringel M, Scannell J, Baedeker M, Schulze U . Breaking Eroom's Law. Nat Rev Drug Discov. 2020; 19(12):833-834. DOI: 10.1038/d41573-020-00059-3. View

18.

Lu H, Zhou Q, He J, Jiang Z, Peng C, Tong R . Recent advances in the development of protein-protein interactions modulators: mechanisms and clinical trials. Signal Transduct Target Ther. 2020; 5(1):213. PMC: 7511340. DOI: 10.1038/s41392-020-00315-3. View

19.

Soleymani F, Paquet E, Viktor H, Michalowski W, Spinello D . Protein-protein interaction prediction with deep learning: A comprehensive review. Comput Struct Biotechnol J. 2022; 20:5316-5341. PMC: 9520216. DOI: 10.1016/j.csbj.2022.08.070. View

20.

Tan R, Liu Y, Xie L . Reinforcement learning for systems pharmacology-oriented and personalized drug design. Expert Opin Drug Discov. 2022; 17(8):849-863. PMC: 9824901. DOI: 10.1080/17460441.2022.2072288. View